-
general info
-
actions of cytoxic agents
-
most are cytotoxic
- low therapeutic index
- dose often measured in mg/meters squared
- low selecivity
-
N/V
- 5HT remaining in GI tract
-
tx: target 5HT
- 5-HT3 blockers
- ondansetron (Zofran)
- p.o./ iv
- gramsetron (Kytril)
- po/iv
- dolasetron (Anzemet)
- iv
- palosetron ( Aloxi)
- iv
-
older tx
- prochlorperazine (Compazine)
- po
- dronabinol (Marinol)
- po
- contains THC
- nabitone (Cesamet)
- analog of THC
- po
- metoclopramide (Reglan)
- stimulates gastric emptying
- D2R inhib
- aprepitant (Emend)
- synthetic cmpd
- neurokinin-1 receptor blocker
- given po before chemo & couple of days after
- iv
- not water soluble
- so you have the phosphoamide version aprepitant posphoamide
- pro-drug
- hydrolyzed in vivo
- fosaprepitant
- iv version
-
bone marrow depression
- myelo depression -> inc incidence of infx and hemmorhage
-
hyperuricemia
- occurs when a cell is killed (get DNA/RNA) --> purines--> oxidized into uric acid
-
tx: urocosurics
- probenacid
-
tx: xanthine oxidase inhib
- allopurinol
- febulostat (Uloric)
-
immunosupression
- causes inc opportunistic infx
- alopecia
- carcinogenic
- teratogenic
- chemo also used in TB
-
cancer
- contact inhibition is lost (they continue to grow on top of each other)
- oncogenes are "turned on" in cancer cells
-
alkylating agents
-
mustard deriv
-
liquid
- cytotoxic
- volatile
- abs rapidly when sprayed
- dec white blood cell count in war survivors
-
used to tx leukemia by replacing "S" with "N"...less volatile
- nitro-mustards
- mechlovethaurias
- SE
- vesicant (causes blistering of the skin)
- not given often (severe bone marrow depression)
- 6 wks
- cyclophosphamide (Cytoxan)
- not alkylating agent bc it's a prodrug converted in vivo
- toxic metabolite acrolein
- 3A4/ 2D6 substrate
- not a vesicant
- for high doses give MESNA or hydrate pt
- 3L a day. day before -3 days after
- tx
- lymphoma, leukemia, breast cancer, ovarian cancer (hard to dx/tx), neuroblastoma, retino blastoma
- admin in AM
- po
- SE
- alopecia
- < bone marrow depression than mechlovethaurias
- hemmorhagic cystitis
- urotox- hematouria characteristic
- excrection of cytoxic products
- cardiotox in high doses > 15mg/m^2
- ifosfamide (Ifex)
- same MOA as cyclophasphamide
- MUST use with MESNA and hydration
- 60% of IFEX dose in 3 doses started when Ifex start
- tx
- testicular cancer
- SE
- hemmorhagic cystitis
- mesno
- highly ionized
- not excreted in urine
- has -HS group stays in blood and reacts w/ ctotoxic agents in blood then excreted in urine
- tx
- hemmorhagic cystitis
-
nitrozourias
- urea gr makes unstable in alkaline (pH of 7.4)
- NO group is the alkalating species
-
tx
- lipid soluble for brain tumors
-
SE
-
bone marrow depression --> seizures
- wait 6 ws between doses
-
lomustine (Ceenu)
- po/iv
- enters CNS easily
-
carmustine (Bienn)
- enters CNS easily
-
platinum deriv
- bind to an alkylate DNA
- all given IV
- removal by renal excretion
-
cisplatin (platinol)
-
SE
- neurotox
- peripheral neuropathy- burning stinging, tingling
- nephrotox
- hydrate pt /mannitol
- Amifostine- expensive given as last resort
- GI tox -N?V
- bone marrow depression
- ototox
- for bladder cancer, testicular,ovarian tumors
- used in combo
-
carboplatin (paraplatin)
- less nephro, neuro, and ototox
-
fewer indications
- tx ovarian & lung cancer
-
dose by calvart equation
- dose in mg= AUC*(25+crcl)
-
oxaliplatin (Eloxatin)
- concerted by hydrolysis to non toxic metabolites then removed by renal excretion
- less toxic of all
- similar toxicities but lower incidence
- less severe
-
persisant parasthesias
- activated by cold
- mostly in face
- used w/ 5-FU for colon cancer
-
purine like analog
-
temozolamide (Temodar)
- converted by hydrolysis to a triazine alkylating agent
- po/iv
-
tx
- astrocytoma resist to nitrozorias
- glioblastomas
-
SE
- bone marrow depression
-
anti-metabolities
- susbstance that compete/interfere with a normal metabolite in the bodys normal metab
-
antifolate
-
5-Formyl THFA (Leucovorin)
- air stable
- can sub for 5,10-methylene THFA
-
antidote for DHFA reductase blockers
- trimethaprim (blocks the DHFA reductase blocker)
- doesnt effect bacteria...only the human
-
methotrexate (MTX)
- inhib of human DHFA reductase
- po/ iv/ intrathecal
- blocks DNA production in cancer cell to kill the cell
- folic acid deriv
-
binds to plasma protiens (50%)
- can be displaced by NSAIDs, sulfonamides,tetracyclines, warfarin, phenytoin
- small therapeutic index
-
elim by glomerular filtration/ tubular secretion
- tubular secretion blocked by NSAIDs/ probenacid/ penicillins
-
cancer tx
- acute leukemia, lymphoma, breast cancer, lung, squamous cell, choriocarcinoma
- rescue therapy in bone cancer (give lethal dose, then rescue with leucovorin)
- with higher doses >1gm/m^2
- given 24 hrs after start of MTX inf
-
non-cancer tx
- psoriasis
- RA
-
tox
- hepato
- assoc w/ long term therapy
- diarheea
- stomatitus -severe hemmorhage
- bone marrow depression
- mucositis
- supplemental folic acid can reduce SE or can reverse therapeutics of it (?)
-
pemetrexed (Alimta)
- inhibits DHFA reductase & thymidylate synthtase
- iv inf w/ cisplatin
-
tx
- malignant pleuro mesothelioma
- non small cell lung cancer (NSCLC)
-
SE
- erythematsus
- puritic rash
- pre-tx w/ dexamethasone
- neutropenia/sepsis
-
req low dose daily folic acid /B-12 supplement
- tell pt not to eat food with excess folc acid i.e. green leafy veggies
- fairly new drug
-
pyrimidine anti metabolites
- to be functional need to be converted to neucleotide in vivo
-
5-Flurouracil (5-FU) (Adrucile )
- inhib thymadilate synthetase
- used w/leucovorin to enhance affinity for thymadilate synthetase
- 1st drug used for solid tissues
-
tx
- iv
- stomach, colon, breast cancer
- too polar to give po
- topically (Efudex)
- pre-malignant keratoses
- basal cell carcinomas
-
leucovorin inc tox
- metab by fdump...in the presence of folates is more stable & binds to TS more tightly
-
SE
- dose limiting tox dependent on administration
- bolus
- myelosupression
- contin inf
- gi related
- mucocytis (inflam of oral cavity)
- give ice chips b4 and during or Kepivance
- given voth ways to tx colon cancer
-
capectitabine (Xeloda)
- pro drug converted in vivo to 5_FU
- can be admin po BID
-
tx
- breast, colorectal
-
SE
- assoc w/ hand foot syndrome
- pain, redness, blistering of palms/soles
- GI: diarrhea
- give immodium
-
cytarabine (Ara-C)
-
very myelosuppressive
- nadar (wbc) 7-14 days
-
SE
- diarrhea (day 3)
- conjunctivitis
- give artificial tears/ steroid eye gtts
- neurotox
- ataxia, nystagmus
- >1gram/m^2
-
gemcitabine
- given iv
- inhibits DNA biosynthesis
-
tx
- ovarian, NSCLC
- unique bc 1st line tx for pancratic cancer
- sx-less until advanced
-
azacytodine (Vidaza)
- SubQ/ iv
- incorporates w/ DNA chain and interferes w/ func of DNA
-
tx
- myelodisplactic syndrome
- collection of bone marrow disorders (primary or secondary)
- primary -de novo spontaneous occurance
- secondary - radiation or chemo
- anemia leucopenia, thrombocytopenia
-
purines
- not used much
-
6-mercaptopurine
-
tx
- leukemia
-
metab by xanthine oxidase
- inhib by allopurinol thus inc toxicity
-
natural products
- alkaloids
- antibiotics
-
microtubule targeting agents
-
vinca alkaloids
-
SE
- neuropathy
- interact with 3A4
-
vincristine (Oncovin)
-
SE
- peripheral neuropathy
- constipation
- SIADH
- max weekly dose od 2mg
- vinblastine
- vinorelbine
-
taxanes
-
Paclitaxel (Taxol)
-
SE
- hypersensitivity rxns
- give benadryl/ decadron/ famotidine
- myelosupression
-
nab-paclitaxol (Abraxane)
-
tx
- taxol resistant cancers
- dec hypersensitivity rxns...can give higher doses
-
docetaxol (Taxotere)
-
SE
- peripheral edema
- decadron decreases incidence
-
misc
-
ixabepilone (Ixempa)
- (-) beta III tubulin subunit
- 3A4 substrate
- req pre-medications